Sign in
Not yet taking people in NetherlandsPhase 1

Oxytocin study in healthy adults to explore migraine-related nerve pathways

Tests oxytocin in healthy adults to study nerve pathways involved in migraine.

Key facts

Who runs it
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Where
Rotterdam, NetherlandsSee the site
Registry title
Oxytocine and migraine
Status
Not yet recruiting
Phase
Phase 1
People taking part
30 people, planned
Started
1 May 2025
Planned end
31 Dec 2025
Type of study
Interventional
Record updated
22 October 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy women to study the trigeminovascular system, which plays a role in migraine.

Age
18 to 64 years
Sex
Women only

This trial only enrols healthy participants. The registry sentence this rests on: This is a study in healthy volunteers.

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Netherlands

  • Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rotterdam, NetherlandsNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Oxytocin study in healthy adults to explore migraine-related nerve pathwaysGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2023-504690-21-00, who can take part
Record updated
22 October 2025